Global At-Home Testing Kits Market - Industry Trends and Forecast to 2029
- Published Date: 2022-12-22
- Report ID: 143262
- Pages: 225
-
Format:
Short Description
Global At-Home Testing Kits Market, By Test Type (Pregnancy Test, HIV Test Kit, Diabetes, Infectious Diseases, Glucose Tests, Ovulation Predictor Test Kit, Drug Abuse Test Kit, and Others), Type (Cassette, Strip, Midstream, Test Panel, Dip Card, and Others), Age (Pediatric, Adult, and Geriatric), Sample Type (Urine, Blood, Saliva, and Others), Usage (Disposable and Reusable), Distribution Channels (Retail Pharmacies, Drug Store, Supermarket/Hypermarket, and Online Pharmacies), Country (U.S., Canada, Mexico, U.K., Germany, France, Spain, Italy, Netherlands, Switzerland, Russia, Belgium, Turkey, Rest of Europe, China, South Korea, Japan, India, Australia, Singapore, Malaysia, Indonesia, Thailand, Philippines, Rest of Asia-Pacific, South Africa, Saudi Arabia, U.A.E., Israel, Egypt, Rest of Middle East and Africa, Brazil, Argentina, Caribbean, Colombia, Peru, Chile, Panama, Venezuela, and Rest of South America) Industry Trends and Forecast to 2029
Market Definition
At-home testing kits means testing instruments which help people to perform tests at home and give them rapid results in a minute. It also includes health monitoring equipment to continuously check and control the health of the diabetic patient. At-home tests are very convenient to perform with comfort at home and are available at very affordable rate. Self-tests are usually the advance versions of rapid, point-of-care test kits that were originally designed for healthcare professionals and can be performed by common person. Their processes, packaging and instructions have been simplified so as to guide person through the steps of taking a test. Various at-home test kits are available including HIV test, pregnancy test, diabetes test, ovulation test, test for infectious diseases such as malaria, COVID-19, and others. For performing these rapid at-home tests, blood, urine, and oral fluid can be taken as a sample.
Market Segmentation
The global at-home testing kits market is categorized into six segments: test type, type, age, sample type, usage, and distribution channels.
On the basis of test type, the global at-home testing kits market is segmented into pregnancy test, HIV test kit, diabetes, infectious diseases, glucose tests, ovulation predictor test kit, drug abuse test kit, and others
On the basis of type, the global at-home testing kits market is segmented into cassette, strip, midstream, test panel, dip card, and others
On the basis of age, the global at-home testing kits market is segmented into pediatric, adult, and geriatric
On the basis of sample type, the global at-home testing kits market is segmented into urine, blood, saliva, and others
On the basis of usage, the global at-home testing kits market is segmented into disposable and reusable
On the basis of distribution channels, the global at-home testing kits market is segmented into retail pharmacies, drug store, supermarket/hypermarket, and online pharmacies
Market Players
The major companies which are dealing in the global at-home testing kits market are listed below:
Abbott, Siemens Healthcare GmbH
F. Hoffmann La-Roche Ltd
Drgerwerk AG & Co. KGaA
LifeScan IP Holdings
Ascensia Diabetes Care Holdings AG
Nectar Lifesciences Ltd. (Rapikit)
ACON Laboratories, Inc.
Quidel Corporation.
ARKRAY USA, Inc.
BTNX INC.
Atomo Diagnostics
Eurofins Scientific
Piramal Enterprises Ltd.
Bionime Corporation
Nova Biomedical
Cardinal Health
OraSure Technologies, Inc.
BioLytical Laboratories Inc.
Everlywell, Inc.
SA Scientific Ltd.
Clearblue
TABLE OF CONTENTS
1 INTRODUCTION 34
1.1 OBJECTIVES OF THE STUDY 34
1.2 MARKET DEFINITION 34
1.3 OVERVIEW OF GLOBAL AT-HOME TESTING KITS MARKET 34
1.4 LIMITATIONS 36
1.5 MARKETS COVERED 36
2 MARKET SEGMENTATION 39
2.1 MARKETS COVERED 39
2.2 GEOGRAPHICAL SCOPE 40
2.3 YEARS CONSIDERED FOR THE STUDY 41
2.4 CURRENCY AND PRICING 41
2.5 DBMR TRIPOD DATA VALIDATION MODEL 42
2.6 MULTIVARIATE MODELLING 45
2.7 GLOBAL AT-HOME TESTING KITS MARKET, BY TEST TYPE 45
2.8 MARKET POSITION COVERAGE GRID 46
2.9 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS 47
2.10 DBMR MARKET POSITION GRID 48
2.11 DISTRIBUTOR CHANNEL ANALYSIS 49
2.12 SECONDARY SOURCES 50
2.13 ASSUMPTIONS 50
3 EXECUTIVE SUMMARY 51
4 PREMIUM INSIGHTS 54
4.1 PESTEL ANALYSIS 57
4.2 PORTER'S FIVE FORCES 58
5 GLOBAL AT- HOME TESTING KITS MARKET: REGULATIONS 59
5.1 REGULATION IN U.S 59
5.2 GUIDELINES FOR SELF-TESTING KITS 59
5.3 REGULATION IN EUROPE 60
5.4 GUIDELINES FOR TESTING KITS 60
5.5 REGULATION IN INDONESIA: 60
6 MARKET OVERVIEW 62
6.1 DRIVERS 64
6.1.1 GROWING ADOPTION OF SELF-TESTING KITS 64
6.1.2 EASY AVAILABILITY OF SELF-TESTING KITS AT PHARMACIES 64
6.1.3 INCREASE IN AWARENESS ABOUT THE IMPORTANCE OF HIV DIAGNOSIS 64
6.1.4 EASE OF USE AND LOW COSTS OF RAPID SELF-TEST KITS 65
6.2 RESTRAINTS 65
6.2.1 INACCURACY OF RESULTS BY SELF-TESTING KITS 65
6.2.2 STRINGENT GOVERNMENT REGULATIONS FOR MANUFACTURING AND DISTRIBUTION OF TESTING KITS 66
6.3 OPPORTUNITIES 67
6.3.1 ADVENT OF ADVANCED TECHNOLOGIES 67
6.3.2 EMERGING NEED FOR RAPID TESTING KITS FOR COVID-19 PANDEMIC 67
6.3.3 STRATEGIC INITIATIVES OF KEY PLAYERS 68
6.4 CHALLENGES 68
6.4.1 HIGH COMPETITION IN THE MEDICAL TECHNOLOGY INDUSTRY 68
6.4.2 REDUCTION IN RESEARCH & DEVELOPMENT BUDGETS 69
7 GLOBAL AT-HOME TESTING KITS MARKET, BY TEST TYPE 70
7.1 OVERVIEW 71
7.2 GLUCOSE TESTS 74
7.3 INFECTIOUS DISEASES 74
7.4 PREGNANCY TEST 75
7.5 DRUG ABUSE TEST KITS 76
7.6 HIV TEST KIT 77
7.7 OVULATION PREDICTOR TEST KIT 78
7.8 OTHERS TEST TYPES 78
8 GLOBAL AT-HOME TESTING KITS MARKET, BY TYPE 80
8.1 OVERVIEW 81
8.2 CASSETTES 84
8.2.1 RETAIL PHARMACIES 85
8.2.2 ONLINE PHARMACIES 85
8.2.3 DRUG STORE 85
8.2.4 SUPERMARKET/HYPERMARKET 85
8.3 STRIP 85
8.3.1 RETAIL PHARMACIES 86
8.3.2 ONLINE PHARMACIES 86
8.3.3 DRUG STORE 86
8.3.4 SUPERMARKET/HYPERMARKET 86
8.4 MIDSTREAM 86
8.4.1 RETAIL PHARMACIES 87
8.4.2 ONLINE PHARMACIES 87
8.4.3 DRUG STORE 87
8.4.4 SUPERMARKET/HYPERMARKET 87
8.5 DIP CARD 88
8.5.1 RETAIL PHARMACIES 88
8.5.2 ONLINE PHARMACIES 89
8.5.3 DRUG STORE 89
8.5.4 SUPERMARKET/HYPERMARKET 89
8.6 TEST PANEL 89
8.6.1 RETAIL PHARMACIES 90
8.6.2 ONLINE PHARMACIES 90
8.6.3 DRUG STORE 90
8.6.4 SUPERMARKET/HYPERMARKET 90
8.7 OTHERS 90
9 GLOBAL AT-HOME TESTING KITS MARKET, BY AGE 92
9.1 OVERVIEW 93
9.2 ADULT 96
9.3 GERIATRIC 96
9.4 PEDIATRIC 97
10 GLOBAL AT-HOME TESTING KITS MARKET, BY SAMPLE TYPE 98
10.1 OVERVIEW 99
10.2 BLOOD 102
10.3 URINE 102
10.4 SALIVA 103
10.5 OTHER SAMPLE TYPES 103
11 GLOBAL AT-HOME TESTING KITS MARKET, BY USAGE 105
11.1 OVERVIEW 106
11.2 DISPOSABLE 109
11.3 REUSABLE 109
12 GLOBAL AT-HOME TESTING KITS MARKET, BY DISTRIBUTION CHANNELS 111
12.1 OVERVIEW 112
12.2 RETAIL PHARMACIES 115
12.3 ONLINE PHARMACIES 115
12.4 DRUG STORE 116
12.5 SUPERMARKET/HYPERMARKET 116
13 GLOBAL AT-HOME TESTING KITS MARKET, BY REGION 118
13.1 OVERVIEW 119
13.2 NORTH AMERICA 124
13.2.1 U.S. 131
13.2.2 CANADA 134
13.2.3 MEXICO 137
13.3 EUROPE 140
13.3.1 GERMANY 147
13.3.2 U.K. 150
13.3.3 FRANCE 153
13.3.4 ITALY 156
13.3.5 SPAIN 159
13.3.6 NETHERLANDS 162
13.3.7 SWITZERLAND 165
13.3.8 RUSSIA 168
13.3.9 TURKEY 171
13.3.10 BELGIUM 174
13.3.11 REST OF EUROPE 177
13.4 ASIA-PACIFIC 178
13.4.1 CHINA 185
13.4.2 JAPAN 188
13.4.3 INDIA 191
13.4.4 SOUTH KOREA 194
13.4.5 AUSTRALIA 197
13.4.6 SINGAPORE 200
13.4.7 INDONESIA 203
13.4.8 THAILAND 206
13.4.9 MALAYSIA 209
13.4.10 PHILIPPINES 212
13.4.11 REST OF ASIA-PACIFIC 215
13.5 SOUTH AMERICA 216
13.5.1 BRAZIL 223
13.5.2 ARGENTINA 226
13.5.3 REST OF SOUTH AMERICA 229
13.6 MIDDLE EAST & AFRICA 230
13.6.1 SOUTH AFRICA 238
13.6.2 SAUDI ARABIA 241
13.6.3 U.A.E 244
13.6.4 ISRAEL 247
13.6.5 EGYPT 250
13.6.6 REST OF MIDDLE EAST & AFRICA 253
14 GLOBAL AT-HOME TESTING KITS MARKET: COMPANY LANDSCAPE 254
14.1 COMPANY SHARE ANALYSIS: GLOBAL 254
14.2 COMPANY SHARE ANALYSIS: NORTH AMERICA 255
14.3 COMPANY SHARE ANALYSIS: EUROPE 256
14.4 COMPANY SHARE ANALYSIS: ASIA-PACIFIC 257
15 SWOT ANALYSIS 258
16 COMPANY PROFILE 259
16.1 ABBOTT 259
16.1.1 COMPANY SNAPSHOT 259
16.1.2 REVENUS ANALYSIS 259
16.1.3 COMPANY SHARE ANALYSIS 260
16.1.4 PRODUCT PORTFOLIO 260
16.1.5 RECENT DEVELOPMENT 260
16.2 SIEMENS HEALTHCARE GMBH 261
16.2.1 COMPANY SNAPSHOT 261
16.2.2 REVENUS ANALYSIS 261
16.2.3 PRODUCT PORTFOLIO 262
16.2.4 RECENT DEVELOPMENTS 262
16.3 F. HOFFMANN- LA ROCHE LTD 263
16.3.1 COMPANY SNAPSHOT 263
16.3.2 REVENUE ANALYSIS 263
16.3.3 COMPANY SHARE ANALYSIS 264
16.3.4 PRODUCT PORTFOLIO 264
16.3.5 RECENT DEVELOPMENTS 264
16.4 BD 265
16.4.1 COMPANY SNAPSHOT 265
16.4.2 REVENUE ANALYSIS 265
16.4.3 PRODUCT PORTFOLIO 266
16.4.4 RECENT DEVELOPMENTS 266
16.5 DRGERWERK AG & CO. KGAA 267
16.5.1 COMPANY SNAPSHOT 267
16.5.2 REVENUE ANALYSIS 267
16.5.3 COMPANY SHARE ANALYSIS 268
16.5.4 PRODUCT PORTFOLIO 268
16.5.5 RECENT DEVELOPMENTS 268
16.6 LIFESCAN IP HOLDINGS, LLC 269
16.6.1 COMPANY SNAPSHOT 269
16.6.2 COMPANY SHARE ANALYSIS 269
16.6.3 PRODUCT PORTFOLIO 270
16.6.4 RECENT DEVELOPMENTS 270
16.7 ASCENSIA DIABETES CARE HOLDINGS AG. 271
16.7.1 COMPANY SNAPSHOT 271
16.7.2 COMPANY SHARE ANALYSIS 271
16.7.3 PRODUCT PORTFOLIO 272
16.7.4 RECENT DEVELOPMENTS 272
16.8 NECTAR LIFESCIENCES LTD. (RAPIKIT) 273
16.8.1 COMPANY SNAPSHOT 273
16.8.2 PRODUCT PORTFOLIO 273
16.8.3 RECENT DEVELOPMENTS 273
16.9 ACON LABORATORIES, INC. 274
16.9.1 COMPANY SNAPSHOT 274
16.9.2 PRODUCT PORTFOLIO 274
16.9.3 RECENT DEVELOPMENTS 274
16.10 QUIDEL CORPORATION. 275
16.10.1 COMPANY SNAPSHOT 275
16.10.2 REVENUE ANALYSIS 275
16.10.3 PRODUCT PORTFOLIO 276
16.10.4 RECENT DEVELOPMENTS 276
16.11 ARKRAY USA, INC. 277
16.11.1 COMPANY SNAPSHOT 277
16.11.2 PRODUCT PORTFOLIO 277
16.11.3 RECENT DEVELOPMENTS 277
16.12 BTNX INC. 278
16.12.1 COMPANY SNAPSHOT 278
16.12.2 PRODUCT PORTFOLIO 278
16.12.3 RECENT DEVELOPMENTS 278
16.13 ATOMO DIAGNOSTICS 279
16.13.1 COMPANY SNAPSHOT 279
16.13.2 REVENUE ANALYSIS 279
16.13.3 PRODUCT PORTFOLIO 280
16.13.4 RECENT DEVELOPMENTS 280
16.14 EUROFINS SCIENTIFIC 281
16.14.1 COMPANY SNAPSHOT 281
16.14.2 REVENUE ANALYSIS 281
16.14.3 PRODUCT PORTFOLIO 282
16.14.4 RECENT DEVELOPMENTS 282
16.15 PIRAMAL ENTERPRISES LTD. 283
16.15.1 COMPANY SNAPSHOT 283
16.15.2 REVENUE ANALYSIS 283
16.15.3 PRODUCT PORTFOLIO 284
16.15.4 RECENT DEVELOPMENTS 284
16.16 BIONIME CORPORATION 285
16.16.1 COMPANY SNAPSHOT 285
16.16.2 REVENUE ANALYSIS 285
16.16.3 PRODUCT PORTFOLIO 286
16.16.4 RECENT DEVELOPMENTS 286
16.17 NOVA BIOMEDICAL 287
16.17.1 COMPANY SNAPSHOT 287
16.17.2 PRODUCT PORTFOLIO 287
16.17.3 RECENT DEVELOPMENTS 287
16.18 CARDINAL HEALTH. 288
16.18.1 COMPANY SNAPSHOT 288
16.18.2 REVENUE ANALYSIS 288
16.18.3 PRODUCT PORTFOLIO 289
16.18.4 RECENT DEVELOPMENTS 289
16.19 ORASURE TECHNOLOGIES 290
16.19.1 COMPANY SNAPSHOT 290
16.19.2 REVENUE ANALYSIS 290
16.19.3 PRODUCT PORTFOLIO 291
16.19.4 RECENT DEVELOPMENTS 291
16.20 BIOLYTICAL LABORATORIES INC. 292
16.20.1 COMPANY SNAPSHOT 292
16.20.2 PRODUCT PORTFOLIO 292
16.20.3 RECENT DEVELOPMENTS 292
16.21.1 COMPANY SNAPSHOT 293
16.21.2 PRODUCT PORTFOLIO 293
16.21.3 RECENT DEVELOPMENTS 293
16.22 SA SCIENTIFIC LTD. 294
16.22.1 COMPANY SNAPSHOT 294
16.22.2 PRODUCT PORTFOLIO 294
16.22.3 RECENT DEVELOPMENTS 294
16.23 CLEARBLUE (A SUBSIDIARY OF SWISS PRECISION DIAGNOSTICS GMBH) 295
16.23.1 COMPANY SNAPSHOT 295
16.23.2 PRODUCT PORTFOLIO 295
16.23.3 RECENT DEVELOPMENTS 295
16.24 BIOSYNEX 296
16.24.1 COMPANY SNAPSHOT 296
16.24.2 PRODUCT PORTFOLIO 296
16.24.3 RECENT DEVELOPMENTS 296
16.25 PRIMA LAB SA 297
16.25.1 COMPANY SNAPSHOT 297
16.25.2 PRODUCT PORTFOLIO 297
16.25.3 RECENT DEVELOPMENTS 298
16.26 MP BIOMEDICALS. 299
16.26.1 COMPANY SNAPSHOT 299
16.26.2 PRODUCT PORTFOLIO 299
16.26.3 RECENT DEVELOPMENTS 299
16.27 STERILAB SERVICES 300
16.27.1 COMPANY SNAPSHOT 300
16.27.2 PRODUCT PORTFOLIO 300
16.27.3 RECENT DEVELOPMENTS 300
16.28 CHEMBIO DIAGNOSTICS, INC. 301
16.28.1 COMPANY SNAPSHOT 301
16.28.2 REVENUE ANALYSIS 301
16.28.3 PRODUCT PORTFOLIO 302
16.28.4 RECENT DEVELOPMENTS 302
16.29 BIOSURE 303
16.29.1 COMPANY SNAPSHOT 303
16.29.2 PRODUCT PORTFOLIO 303
16.29.3 RECENT DEVELOPMENTS 303
16.30 SELFDIAGNOSTICS OU 304
16.30.1 COMPANY SNAPSHOT 304
16.30.2 PRODUCT PORTFOLIO 304
16.30.3 RECENT DEVELOPMENTS 304
17 QUESTIONNAIRE 305
18 RELATED REPORTS 308
Call Us
( India toll free )
+91 835 605 0278
( US toll free )
+1 800 601 6071
Drop us an email at
sales@prudentmarkets.com
Get your pre and post sales queries resolved by our Subject matter experts.
We will assist you to customize the report to fit your research needs.
Our prime focus is to provide qualitative and accurate data.
Feel free to order a sample report before purchase.
Your personal and confidential information is safe and secured.
